Faculty Bibliography

Try a new search

Format these results:

Searched for:

in-biosketch:true

person:parkk10

Total Results:

41

Journal of clinical oncology. 2009:27.DOI:

Phase IIb/III double-blind randomized trial of BIBW 2992, an irreversible, dual inhibitor of EGFR and HER2 plus best supportive care (BSC) versus placebo plus BSC in patients with NSCLC failing 1-2 lines of chemotherapy (CT) and erlotinib or gefitinib (LUX-Lung1): A preliminary report [Meeting Abstract]

Yang, C.; Hirsh, V.; Cadranel, J.; Chen, Y.; Park, K.; Kim, S.; Chao, T.; Oberdick, M.; Shahidi, M.; Miller, V.
ISI:000276606605264
ISSN: 0732-183x
CID: 3159092